Symbols

HTGC

Hercules Capital·NYSE

--(--)

HTGC fundamentals

HTGC Q4 2025 Earnings

Hercules Capital (HTGC) released its earnings on Feb 12, 2026: revenue was 137.40M (YoY +12.81%), missed estimates; EPS was 0.48 (YoY -2.04%), missed estimates.

Revenue / YoY

137.40M

+12.81%

EPS / YoY

0.48

-2.04%

Report date

Feb 12, 2026

HTGC Earnings Call Summary for Q4,2025

Record Growth: Q4 originations $1.06B, annual originations $3.92B (45.7% YoY), gross fundings $2.28B (25.9% YoY).
Liquidity Boost: $300M bond issuance post-Q4, $1B+ platform liquidity.
Defensive Strategy: 69% Q4 life sciences focus, LTV <20%, DTE <30%, 91% PIK in Grade 1-3 credits.
AI Integration: 86% PIK from original underwriting, portfolio companies embedding AI into core products.
Distribution Stability: 120% base dividend coverage, 22nd straight quarter of supplemental distributions.
Q1 Momentum: $1.2B+ commitments, targeting dislocated deals with conservative underwriting.

Earnings

EPS

Revenue

Revenue & Expenses

Key Indicators

Hercules Capital (HTGC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Hercules Capital (HTGC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Hercules Capital (HTGC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Hercules Capital (HTGC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown